Fingerprint
Dive into the research topics where Elie Traer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Phase 1b study of ABBV-744, a novel, selective BET inhibitor, as monotherapy for patients with myelofibrosis
Mascarenhas, J., Fogliatto, L., Green, S., Corvalan, I., Traer, E., Kirito, K., Chuah, H., Sakatoku, K., Hoeg, R., Khawandanah, M., Lavie, D., Hunter, Z., Quinn, D., Wang, Y., Harb, J., Zha, J., Malyankar, U. & Ritchie, E., May 26 2026, In: Blood Advances. 10, 10, p. 3543-3553 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Results of a phase 1 trial testing ruxolitinib plus venetoclax in patients with relapsed/refractory acute myeloid leukemia
Borate, U., Tognon, C. E., Madanat, Y. F., Misra, S., Kaempf, A., Patel, P. A., Davis, K. L., Sun, J., Stuani, L., Eisenmann, E. D., Eide, C. A., Kurtz, S. E., Watanabe-Smith, K., Johnson, K., Jager, A., Gullaksen, S. E., Robinson, B., Vu, T., Plevritis, S. K. & Baker, S. D. & 17 others, , May 1 2026, In: Blood Neoplasia. 3, 2, 100205.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical outcomes of older patients with NPM1-mutated or KMT2A-rearranged AML before menin inhibitors: a Beat AML report
Zeidner, J. F., Jain, J., Welkie, R. L., Huang, Y., Swords, R. T., Traer, E., Stein, E. M., Lin, T. L., Madanat, Y. F., Collins, R. H., Baer, M. R., Duong, V. H., Blum, W. G., Arellano, M. L., Stock, W., Odenike, O., Olin, R. L., Smith, C. C., Foran, J. M. & Schiller, G. J. & 15 others, , Apr 14 2026, In: Blood Advances. 10, 7, p. 2328-2332 5 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
IDH2 mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapy
Hoff, F. W., Huang, Y., Welkie, R. L., Swords, R. T., Traer, E., Stein, E. M., Lin, T. L., Baer, M. R., Duong, V. H., Blum, W. G., Arellano, M. L., Stock, W., Odenike, O., Zeidner, J. F., Olin, R. L., Smith, C. C., Schiller, G. J., Curran, E. K., Handa, S. V. & Heerema, N. A. & 13 others, , Jan 1 2026, In: Haematologica. 111, 5, p. 1625-1633 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial
Hoff, F. W., Huang, Y., Welkie, R. L., Swords, R. T., Traer, E., Stein, E. M., Lin, T. L., Patel, P. A., Collins, R. H., Baer, M. R., Duong, V. H., Blum, W. G., Arellano, M. L., Stock, W., Odenike, O., Redner, R. L., Kovacsovics, T., Deininger, M. W., Zeidner, J. F. & Olin, R. L. & 19 others, , Dec 1 2025, In: Blood cancer journal. 15, 1, 55.Research output: Contribution to journal › Letter › peer-review
Open Access7 Link opens in a new tab Scopus citations